Cecil D. Haney, Retired 4-Star Admiral Is Appointed to Tenet Healthcare Board of Directors

January 8, 2020

Cecil D. Haney has been appointed to Tenet Healthcare Board of Directors, effective immediately. This appointment expands the Board to include 12 directors.

Ron Rittenmeyer, the Executive Chairman and CEO, said, “Cecil has demonstrated the true tenets of servant leadership throughout his incredibly distinguished career in the U.S. military. He is an extraordinary individual and leader who will complement our Board, particularly in the areas of cybersecurity and systems planning. We look forward to working with him.”

Cecil D. Haney is a retired four-star Admiral, who completed 38 years of service in the U.S. Navy. He served as commander of the U.S. Strategic Command, where he was responsible for strategic capabilities involving nuclear forces, missile defense, space and cyberspace. He also served as commander of the U.S. Pacific Fleet, leading the U.S. Navy’s operations and the manning, operations and maintenance of the U.S. Navy fleet located in the Pacific and Indian oceans.

As a career U.S. Navy submariner, Cecil D. Haney held a number of leadership positions in the submarine force and in joint assignments. He also served as a member of the Congressionally-mandated Military Leadership Diversity Commission.

He currently serves on the Johns Hopkins University Applied Physics Board of Managers, the Naval Studies Board, the Aerospace Corporation Board of Trustees and the Board of Directors for General Dynamics Corporation, Systems Planning and Analysis Inc., and the Center for New American Security. He also serves as Chairman of the Board of Directors for the Military Child Education Coalition.

Haney is a graduate of the U.S. Naval Academy and holds Master’s degrees in National Security Strategy from the National Defense University and in Engineering Acoustics and System Technology from the Naval Post Graduate School.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution